vTv Therapeutics Inc. is facing delisting from the Nasdaq Stock Market due to their common stock's bid price being below $1.00 per share for 30 consecutive business days, a breach of the Minimum Bid Requirement. The company has requested a hearing to appeal the delisting, and was granted an extension to regain compliance by December 18, 2023. The company has proposed to effect a reverse stock split by November 22, 2023 to regain compliance.